Literature DB >> 19244131

Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling.

Liat Fux1, Nir Feibish, Victoria Cohen-Kaplan, Svetlana Gingis-Velitski, Sari Feld, Chen Geffen, Israel Vlodavsky, Neta Ilan.   

Abstract

Heparanase is an endo-beta-d-glucuronidase capable of cleaving heparan sulfate, activity that is strongly implicated in cellular invasion associated with tumor metastasis, angiogenesis, and inflammation. In addition, heparanase was noted to exert biological functions apparently independent of its enzymatic activity, enhancing the phosphorylation of selected protein kinases and inducing gene transcription. A predicted three-dimensional structure of constitutively active heparanase clearly delineates a TIM-barrel fold previously anticipated for the enzyme. Interestingly, the model also revealed the existence of a COOH-terminal domain (C-domain) that apparently is not an integral part of the TIM-barrel fold. We provide evidence that the C-domain is critical for heparanase enzymatic activity and secretion. Moreover, the C-domain was found to mediate nonenzymatic functions of heparanase, facilitating Akt phosphorylation, cell proliferation, and tumor xenograft progression. These findings support the notion that heparanase exerts enzymatic activity-independent functions, and identify, for the first time, a protein domain responsible for heparanase-mediated signaling. Inhibitors directed against the C-domain, combined with inhibitors of heparanase enzymatic activity, are expected to neutralize heparanase functions and to profoundly affect tumor growth, angiogenesis, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244131      PMCID: PMC2650747          DOI: 10.1158/0008-5472.CAN-08-1837

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Heterodimer formation is essential for heparanase enzymatic activity.

Authors:  Flonia Levy-Adam; Hua-Quan Miao; Robert L Heinrikson; Israel Vlodavsky; Neta Ilan
Journal:  Biochem Biophys Res Commun       Date:  2003-09-05       Impact factor: 3.575

2.  Processing and activation of latent heparanase occurs in lysosomes.

Authors:  Anna Zetser; Flonia Levy-Adam; Victoria Kaplan; Svetlana Gingis-Velitski; Yulia Bashenko; Shay Schubert; Moshe Y Flugelman; Israel Vlodavsky; Neta Ilan
Journal:  J Cell Sci       Date:  2004-05-01       Impact factor: 5.285

3.  Protein structure prediction and analysis using the Robetta server.

Authors:  David E Kim; Dylan Chivian; David Baker
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts.

Authors:  Ilya Sotnikov; Rami Hershkoviz; Valentin Grabovsky; Neta Ilan; Liora Cahalon; Israel Vlodavsky; Ronen Alon; Ofer Lider
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

5.  Mechanism of activation of human heparanase investigated by protein engineering.

Authors:  Caterina Nardella; Armin Lahm; Michele Pallaoro; Mirko Brunetti; Alessandro Vannini; Christian Steinkühler
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

6.  Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

Authors:  Edward McKenzie; Kathryn Young; Margaret Hircock; James Bennett; Maina Bhaman; Robert Felix; Paul Turner; Alasdair Stamps; David McMillan; Giles Saville; Stanley Ng; Sean Mason; Daniel Snell; Darren Schofield; Haiping Gong; Reid Townsend; John Gallagher; Martin Page; Raj Parekh; Colin Stubberfield
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

7.  Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

Authors:  Evgeny Edovitsky; Michael Elkin; Eyal Zcharia; Tamar Peretz; Israel Vlodavsky
Journal:  J Natl Cancer Inst       Date:  2004-08-18       Impact factor: 13.506

8.  Heparanase affects adhesive and tumorigenic potential of human glioma cells.

Authors:  Anna Zetser; Yulia Bashenko; Hua-Quan Miao; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

9.  Heparanase induces endothelial cell migration via protein kinase B/Akt activation.

Authors:  Svetlana Gingis-Velitski; Anna Zetser; Moshe Y Flugelman; Israel Vlodavsky; Neta Ilan
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

10.  Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.

Authors:  Svetlana Gingis-Velitski; Anna Zetser; Victoria Kaplan; Olga Ben-Zaken; Esti Cohen; Flonia Levy-Adam; Yulia Bashenko; Moshe Y Flugelman; Israel Vlodavsky; Neta Ilan
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

View more
  49 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.

Authors:  Yi Qing He; Elissa L Sutcliffe; Karen L Bunting; Jasmine Li; Katharine J Goodall; Ivan K A Poon; Mark D Hulett; Craig Freeman; Anjum Zafar; Russell L McInnes; Toshiki Taya; Christopher R Parish; Sudha Rao
Journal:  Transcription       Date:  2012 May-Jun

3.  Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.

Authors:  Geetha Rao; Dingxie Liu; Mingzhao Xing; Jordi Tauler; Richard A Prinz; Xiulong Xu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

4.  Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.

Authors:  Marina Weissmann; Gil Arvatz; Netanel Horowitz; Sari Feld; Inna Naroditsky; Yi Zhang; Mary Ng; Edward Hammond; Eviatar Nevo; Israel Vlodavsky; Neta Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

5.  Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.

Authors:  Camilla A Thompson; Anurag Purushothaman; Vishnu C Ramani; Israel Vlodavsky; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

6.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

Review 7.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

8.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 9.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

10.  Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

Authors:  Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.